Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
36
0
2

Year Published

2016
2016
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 131 publications
(38 citation statements)
references
References 90 publications
(91 reference statements)
0
36
0
2
Order By: Relevance
“…On the other hand, our average in-hospital costs of endovascular treatment for CLI ($4 763.72 per year and $13.05 per day), resulting in individually different amputation-free survival periods, were lower than the threshold for the estimation of the cost-effectiveness of medical intervention for one QALY, as determined in Poland in January 2016 at the level of 345.08 PLN ($88.48) per day. This means that lower limb revascularization and salvation, even for a limited amputation-free survival period, should be recognized as a worthwhile and cost-effective procedure, which is supported by other authors [5,[9][10][11][12][13]. The resource expenditure linked with endovascular procedures might be further decreased by the selective use of stents and other expensive devices [9,14].…”
Section: Discussionmentioning
confidence: 71%
See 1 more Smart Citation
“…On the other hand, our average in-hospital costs of endovascular treatment for CLI ($4 763.72 per year and $13.05 per day), resulting in individually different amputation-free survival periods, were lower than the threshold for the estimation of the cost-effectiveness of medical intervention for one QALY, as determined in Poland in January 2016 at the level of 345.08 PLN ($88.48) per day. This means that lower limb revascularization and salvation, even for a limited amputation-free survival period, should be recognized as a worthwhile and cost-effective procedure, which is supported by other authors [5,[9][10][11][12][13]. The resource expenditure linked with endovascular procedures might be further decreased by the selective use of stents and other expensive devices [9,14].…”
Section: Discussionmentioning
confidence: 71%
“…Thus, a high percentage of CLI treatment fails and the lack of at least one-year of benefits from lower limb revascularization in 55% of patients with CLI may suggest that interventional therapy in patients with CLI is not cost-effective and leads only to ineffective resource utilization. In this context, in spite of endovascular therapy for lower limb ischemia being recognized as a significantly less costly procedure than surgery without significant differences in amputationfree survival [5], primary leg amputation in CLI patients might seem to be a better option for patients with CLI, especially in individuals for whom there are risk factors for poor treatment outcome [6]. However, such risk-factor scores for CLI have still not been published [7].…”
Section: Introductionmentioning
confidence: 99%
“…Our sample reported smoking 04 cases (44.4%), lipid metabolism disorders has 08 cases (88.9%). According to other documents [2,3], smoking and lipid metabolic disorders becomes a factor accelerating the process of pathological blood vessels, increases the severity of the disease and significant impact on disease chronic arterial occlusion of the lower extremities.…”
Section: Discussionmentioning
confidence: 99%
“…Beyond high-performance techniques in reconstructing arterial flow [72][73][74][75][76][77][78][79][80][81][82][83][84][85][86], new strategies about "when" and "where" to perform appropriate revascularization emerge today [1,27,30,35]. Contemporary practitioners equally avail key data on the molecular mechanisms generating ischemic threat and tissue regeneration [59][60][61].…”
Section: New Strategies For "Wound Targeted Revascularization"mentioning
confidence: 99%